1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Opiate Dependence: new trials by email Literature Review of Opiate Dependence trials Research Report on Opiate Dependence
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ALK21-006EXT: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol- or Opioid-dependent Adults (Extension of Study ALK21-006 [NCT01218997]) Medisorb naltrexone 380 mg, Oral naltrexone to Medisorb naltrexone 380 mg - Alcoholism, Opiate Dependence | Phase 3 | Terminated | Alkermes, Inc. | 108 | 2004-08-01 | 2010-11-17 |
Alcoholism (1) · Opioid-Related Disorders (1)
Alcohol-Related Disorders (1) · Chemically-Induced Disorders (1) · Mental Disorders (1) · Narcotic-Related Disorders (1) · Substance-Related Disorders (1)
Naltrexone (1) · vivitrol (1)
Alkermes, Inc. (1)